The expression of co-stimulatory molecules on DCs, including CD80 and CD86, is notably increased in vitiligo patients (73), enhancing their antigen-presenting ability and promoting the activation and proliferation of T cells, particularly CD8+ T cells, which contribute to the destruction of melanocytes. Here, CD86 is linked to vitiligo.